Silhouette
Upgrade to view details

KATHRYN KOSUDA

Vaxess Technologies, Inc.

Message

Employers

Affiliated Awards

Award Title Agency Phase Award amount Start Date End Date
SBIR Phase II: A New Approach to Developing a Heat-stable Rotavirus Vaccine
Vaxess Technologies, Inc.
Firm POC
NSF 2 $750K 10/01/16 09/30/18
Development of a Silk-Stabilized Inactivated Polio Vaccine
Vaxess Technologies, Inc.
Principal Investigator
HHS 1 $210K 03/01/15 08/31/15
SBIR Phase I: Silk: A New Approach to Developing a Heat-stable Rotavirus Vaccine
Vaxess Technologies, Inc.
Firm POC
NSF 1 $150K 01/01/15 12/31/15